Michael T. Chin
*This article is a correction to:
A novel αB-crystallin R123W variant drives hypertrophic cardiomyopathy by promoting maladaptive calcium-dependent signal transduction
CORRECTION article
Front. Cardiovasc. Med.
Sec. Cardiovascular Genetics and Systems Medicine
Volume 11 - 2024 |
doi: 10.3389/fcvm.2024.1455263
Frontiers Corrigendum Template for Authors
Provisionally accepted- Tufts Medical Center, Boston, United States
The final, formatted version of the article will be published soon.
Keywords: Hypertrophic Cardiomyopathy, cardiac hypertrophy, CryAB, Calcineurin, NFAT, transverse aortic constriction, cardiac fibrosis
Received: 26 Jun 2024; Accepted: 27 Jun 2024.
Copyright: © 2024 Chin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Michael T. Chin, Tufts Medical Center, Boston, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.